By: Lani Hessen, Director of Advocacy, Cognoa, and Pediatric Occupational Therapist (OTR/L) Autism impacts an estimated 1 in 54 children in the U.S. today. Autism is a spectrum, representing a tremendous range of skills and challenges spanning learning and communication, socialization and developmental behaviors. Autism impacts children and families of all backgrounds, regardless of race, ethnicity, location, or wealth. As…
An Interview with Cognoa’s CEO Brent Vaughan In the US, one in five children are living with a diagnosable behavioral health disorder; however, only 21% of those children who are diagnosed receive needed treatment. Often, parents have to wait one to three years to receive a proper and accurate diagnosis, and an individualized treatment plan for their child. For the last 15 years, the average…
Halim Abbas, Ford Garberson, Stuart Liu-Mayo, Eric Glover & Dennis P. Wall Scientific Reports volume 10, Article number: 5014 (2020) Cite this article 2 Altmetric | Metricsdetails Abstract Autism has become a pressing healthcare challenge. The instruments used to aid diagnosis are time and labor expensive and require trained clinicians to administer, leading to long wait times for at-risk children. We present a multi-modular, machine learning-based assessment of autism comprising three complementary modules…
Ronit Molko, Ph.D., BCBA-D describes how AI will become the norm of autism services, as it has in other industries, including Cognoa’s digital therapeutics that create a more proactive role for parents and pediatricians in the diagnostic and treatment processes to accomplish early intervention. Read full article here.
Pediatric digital therapeutics developer Cognoa has teamed up with Autism Learning Partners, a specialized treatment provider, to put its autism screening app in the hands of parents to help track their children’s development. Read the full article here.
WRITTEN BY Shannon Ashley The American Academy of Pediatrics (AAP) recommends that all children get screened for autism spectrum disorder at their 18- and 24-month well-child checkups. Today, those recommendations have been significantly enhanced. These new guidelines now recommend developmental and behavioral surveillance at 9-, 18-, and 30-month visits in addition to the standardized ASD screening at 18 and 24 months old.…
Rosmary Ros‐Demarize, Catherine Bradley, Stephen M. Kanne, Zachary Warren, Andrea Boan, Clara Lajonchere, Justine Park, Laura Arnstein Carpenter Abstract Although considerable work has documented higher prevalence rates of autism spectrum disorder (ASD) in boys, fewer studies have focused on sex differences within samples of young children at‐risk for ASD. This study examined sex differences in ASD symptom domains and ASD screening outcomes…
By Brent Vaughan, CEO and Co-Founder, Cognoa. We are experiencing a mental health crisis:one person in every four in the world will develop one or more behavioral conditions during their lifetime. Today in the U.S., one in five children have a diagnosable behavioral health disorder and only 21% of those children receive needed treatment. Read full article here.
Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said. Read full article here.
Du Y1,2, Abbas H2, Taraman S1,2,3, Segar S2, Bischoff N2. Author information 1University of California, Irvine, CA, USA.2Cognoa Inc., Palo Alto, CA, USA.3Children’s Hospital of Orange County, Orange, CA, USA. Abstract Early identification and intervention of speech and language delays in children contribute to better communication and literacy skills for school readiness and are protective against behavioral and mental health problems. Through collaboration between…
